G

Genus

Global animal genetics and breeding technology

Production Technician

Full-TimeDeadline 8/1/27
No salary listed
Mid
Bachelor's
Saskatchewan, Canada
In Person
Medical, Clinical & VeterinaryVeterinary Professionals

About the job

Requirements
  • An animal sciences degree, diploma, or certificate is required.
  • Ability to work both autonomously and within a team environment.
  • Ability to follow instructions and deal with standardized situations.
  • Ability to work in and maintain performance expectations in a fast-paced environment.
  • Attention to detail and ability to meet deadlines.
  • Minimal, if any, travel is required.
Responsibilities
  • Perform daily animal husbandry tasks in support of breeding and scientific research, including pig placement, pig healthcare and medication, feeding management, environment, water and ventilation management, off testing, blood sample collection, and production record keeping.
  • Maintain accurate and timely production information and records as required by supervising agricultural sciences professionals.
  • Assist in moving animals and maintaining efficient animal flows.
  • Complete all tasks pertaining to farrowing, including fostering, weaning, and processing litters.
  • Treat sick animals with pharmaceuticals by injection, oral application, or other required methods.
  • Maintain facility biosecurity by sanitizing and washing multiple areas using high-pressure equipment, and perform office cleanliness and laundry duties to avoid contamination of animals and research samples.
  • Change plans according to the direction of farm leadership when required.
  • Adhere to the company's animal care policies and procedures, including meeting animals' environmental needs, providing adequate water and high-quality feed, humane treatment, identifying and appropriately treating animals needing healthcare, and following euthanasia guidelines.
  • Read and understand the company's emergency notification process and its application to the specific worksite.
  • Follow company policies, procedures, and guidelines directed by farm leadership, including safety requirements, biosecurity protocols, and environmental laws and procedures; report environmental issues immediately to a supervisor.
  • Work as a team member to accomplish daily department work requirements and farm goals.
Desired Qualifications
  • Previous livestock handling experience.

About the company

Genus is a global animal-genetics company focused on improving cattle and pig performance through breeding and genetic technologies. It operates two main units, ABS Global for bovine genetics and PIC for porcine genetics, offering breeding animals, reproduction services, and gene-editing and next-generation breeding tools. Its products work by combining genetics, reproductive biology, and data-driven selection to produce healthier herds, higher-quality food, and more efficient production. Genus differentiates itself through its global scale (operations in 30 countries and distribution to over 50 markets), its specialized units for cattle and pigs, and its integration of science with practical farming solutions. Its goal is to sustainably nourish the world by improving animal health, food quality, and the resilience of the global food system, while delivering value to customers and upholding ethical, collaborative values.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Basingstoke, United Kingdom

Founded

1933

Get referred to Genus

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Genus said 14 July 2026 FY26 results should beat consensus and cut leverage.
  • The Chinese porcine joint venture delivered about £111 million cash in FY26.
  • ABS posted double-digit profit growth in FY26, helped by the Value Acceleration Programme.

What critics are saying

  • North American PIC volumes weakened in FY26 from customer disease challenges.
  • Genus still depends on further approvals before selling PRRS-resistant pigs in Canada.
  • If EU and U.S. adoption stalls, PRRS-resistant pigs stay a stranded platform.

What makes Genus unique

  • PIC’s PRRS-resistant pigs won Canada approval on 23 January 2026.
  • Genus monetizes elite genetics through recurring royalties, not commodity livestock sales.
  • ABS and PIC combine bovine and porcine genetics across 100-plus countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Parental Leave

Employee Stock Purchase Plan

Paid Holidays

Paid Vacation

Tuition Reimbursement

Flexible Work Hours

Company News

Associated Press
Jan 23rd, 2026
Canada approves PRRSV-resistant pigs for food and feed to cut farm losses and antibiotic use

Canada has approved genetically engineered pigs resistant to porcine reproductive and respiratory syndrome viruses for use in food and feed. Health Canada and the Canadian Food Inspection Agency completed independent safety assessments following applications from Genus PLC and PIC Canada, concluding the pigs are as safe and nutritious as conventional pork. The approval addresses PRRSV, one of the most devastating virus classes affecting farmed pigs, which causes severe symptoms including breathing problems, fever and stillborn piglets. There are currently no effective treatments available. Genus PLC's PRRSV-resistant pigs are already approved in the US, Brazil, Colombia and the Dominican Republic. However, the company will not sell these pigs in Canada until receiving regulatory authorisation in other key markets. Canada's swine industry generated over $6.3 billion in farm cash receipts in 2024.

TipRanks
Oct 21st, 2024
Genus plc CFO to Retire, Successor Search Underway

Genus plc, a global leader in animal genetics, has announced the upcoming retirement of its Chief Financial Officer, Alison Henriksen, who will leave her role in July 2025 after five years with the company.

PharmiWeb
Sep 7th, 2023
Genus Plc Preliminary Results For The Year Ended 30 June 2023

SOLID PERFORMANCE AND GOOD STRATEGIC PROGRESSWEBCAST AVAILABLE AT 7:01AM GMT, 2.01 ESTLONDON--(BUSINESS WIRE)--Genus (LSE:GNS), a leading global animal genetics company, today announces its preliminary results for the year ended 30 June 2023. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 EST.Commenting on the performance and outlook, Jorgen Kokke, Chief Executive Officer, said:“The Group achieved a strong operational performance despite ongoing challenging market conditions for producers in several important markets. Revenues grew in all regions and both PIC and ABS delivered profit growth. This also enabled us to deliver record adjusted EBITDA and good cashflow for the Group. Growth in R&D investments, primarily due to the strategically important gene editing work and expansion of PIC’s elite farms, as well as higher interest costs, resulted in adjusted profit before tax consistent with the prior year.“PIC’s performance was particularly impressive, achieving a record adjusted operating profit for the year

MarketWatch
Apr 3rd, 2023
Genus Names Jorgen Kokke as Chief Executive Officer Designate

Genus PLC said Monday that it has appointed Jorgen Kokke as chief executive officer designate, effective from May 2.

PharmiWeb
Sep 8th, 2022
Genus Plc Reports Preliminary Results For The Year Ended 30 June 2022

Continued Strategic Progress in Challenging Markets. Webcast Available at 7:01AM BST, 2.01 EDT